Agilent Technologies (A) is set to report its third-quarter fiscal 2024 results on Aug 21.For the fiscal third quarter, the company expects revenues of $1.535-$1.575 billion, suggesting a decline of 8.2-5.8% on a reported basis and 6.9-4.5% on a core basis from the year-ago quarter’s actuals. The Zacks Consensus Estimate for the same is pegged at $1.56 billion, implying a decline of 6.6% from the year-ago quarter’s reported figure.Agilent’s non-GAAP earnings per share are expected to be $1.25-$1.28. The Zac ...

Wall Street analysts expect Agilent Technologies (A) to post quarterly earnings of $1.25 per share in its upcoming report, which indicates a year-over-year decline of 12.6%. Revenues are expected to be $1.56 billion, down 6.6% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company announ ...

Agilent Technologies (A) recently launched its new ProteoAnalyzer system at the Singapore Cell and Gene Therapy Pan Asia Summit.ProteoAnalyzer is an automated parallel capillary electrophoresis solution, enabling rapid, high-resolution protein analysis with minimal sample consumption, facilitating faster discoveries for researchers.This biomolecular platform aims to elevate translational research from compound to novel applications. The platform includes easy-to-use QC workflows for assessing protein size a ...

These are solid stocks that have all generated 10-year returns in excess of 200%.The S&P 500 has remained red hot, achieving gains of nearly 15% through the first six months of 2024. Healthcare stocks have performed well, but not nearly to the same extent -- the Healthcare Select Sector SPDR ETF has risen by 7% during the first half of this year.Healthcare stocks may not generate as much excitement as other growth stocks, but there are some solid options that you can buy and hold, not just for the second pa ...

A month has gone by since the last earnings report for Agilent Technologies (A) . Shares have lost about 0.5% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Agilent due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Agilent Q2 Earnings Beat EstimatesAgilent Technolo ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Agilent Technologies, Inc. (A) is an application-focused solutions provider to the life sciences, diagnostics, and applied chemical markets. The Zacks Consensus Estimate for its current year earnings has been revised 4% downward over the last 60 days.Avis Budget Group, Inc. (CAR) is a car and truck rental company. The Zacks Consensus Estimate for its current year earnings has been revised 19.6% downward over the last 60 days.B&G Foods ...

Agilent Technologies (A) is leaving no stone unturned to capitalize on growth opportunities present in the global mass spectrometry (MS) market, which, per a Mordor Intelligence report, is expected to hit $6.77 billion in 2024 and reach $9.17 billion by 2029, witnessing a CAGR of 6.3% between 2024 and 2029.In this regard, the company recently introduced two new products, namely the Agilent 7010D Triple Quadrupole gas chromatography (GC)-MS System and the Agilent ExD Cell.The Agilent 7010D Triple Quadrupole ...

Agilent Technologies, Inc. (NYSE:A) Jefferies 2024 Global Healthcare Conference June 5, 2024 8:30 AM ET Company Participants Robert McMahon - Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Tycho Peterson All right, we're good to go. Good morning, everyone. I'm a Tycho Peterson from the life science team here at Jefferies. Pleased to introduce Bob McMahon from Agilent. Robert McMahon Great, thanks. Thanks, Michael. Good to see you. Great to be here ...

Agilent Technologies, Inc. (NYSE:A) Jefferies 2024 Global Healthcare Conference June 5, 2024 8:30 AM ET Company Participants Robert McMahon - Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Tycho Peterson All right, we're good to go. Good morning, everyone. I'm a Tycho Peterson from the life science team here at Jefferies. Pleased to introduce Bob McMahon from Agilent. Robert McMahon Great, thanks. Thanks, Michael. Good to see you. Great to be here ...

Have you assessed how the international operations of Agilent Technologies (A) performed in the quarter ended April 2024? For this scientific instrument maker, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.In today's increasingly interconnected global economy, a company's ability to tap into international markets can be a pivotal factor in shaping its overall financial health and growth trajecto ...